| SSRI | Selective serotonin reuptake inhibitor |
| DDIs | Drug–drug interactions |
| TDM | Therapeutic drug monitoring |
| AGNP | Arbeitsgemeinschaft für Neuropsychopharmakologie und Pharmakopsychiatrie |
| PK | Pharmacokinetics |
| PGx | Pharmacogenetics |
| ADRs | Adverse drug reactions |
| C/D | Concentration-to-dose ratio |
| MR | Sertraline-to-norsertraline metabolic ratio |
| MRDN | Metabolic ratio dose-normalized |
| LogMR | Log10-transformed sertraline/norsertraline metabolic ratio |
| LogMRDN | Log10-transformed dose-normalized sertraline/norsertraline metabolic ratio |
| BMI | Body mass index |
| PCR | Polymerase chain reaction |
| LLOQ | Lower limit of quantification |
| BP | Breusch–Pagan |
| gUM | Genotype-predicted ultrarapid metabolizers |
| gIM | Genotype-predicted intermediate metabolizers |
| gPM | Genotype-predicted poor metabolizers |
| gNM | Genotype-predicted normal metabolizers |
| gRM | Genotype-predicted rapid metabolizers |
| CPIC | Clinical Pharmacogenetics Implementation Consortium |
| DPWG | Dutch Pharmacogenetics Working Group |
| ESI | Electrospray ionization |
| ALT | Alanine aminotransferase |
| AST | Aspartate aminotransferase |
| GGT | Gamma-glutamyl transferase |
| ALP | Alkaline phosphatase |
| UGTs | UDP-glucuronosyltransferases |